Your browser is no longer supported. Please, upgrade your browser.
EVOK [NASD]
Evoke Pharma, Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own3.05% Shs Outstand32.37M Perf Week1.48%
Market Cap43.40M Forward P/E- EPS next Y-0.31 Insider Trans0.00% Shs Float31.38M Perf Month8.73%
Income-14.00M PEG- EPS next Q-0.08 Inst Own12.20% Short Float3.15% Perf Quarter-29.38%
Sales0.10M P/S434.02 EPS this Y-61.50% Inst Trans52.35% Short Ratio2.54 Perf Half Y-52.60%
Book/sh0.25 P/B5.48 EPS next Y8.80% ROA-127.70% Target Price- Perf Year-63.95%
Cash/sh0.57 P/C2.38 EPS next 5Y40.00% ROE- 52W Range1.09 - 6.06 Perf YTD-46.90%
Dividend- P/FCF- EPS past 5Y22.70% ROI- 52W High-77.57% Beta1.08
Dividend %- Quick Ratio3.00 Sales past 5Y- Gross Margin-33.50% 52W Low24.77% ATR0.10
Employees5 Current Ratio3.10 Sales Q/Q- Oper. Margin- RSI (14)47.90 Volatility5.85% 7.90%
OptionableYes Debt/Eq0.64 EPS Q/Q-14.20% Profit Margin- Rel Volume0.15 Prev Close1.37
ShortableYes LT Debt/Eq0.64 EarningsMay 12 AMC Payout- Avg Volume388.25K Price1.36
Recom2.00 SMA202.03% SMA50-5.53% SMA200-52.43% Volume22,559 Change-0.73%
Jun-22-20Upgrade H.C. Wainwright Neutral → Buy $10
Mar-05-19Downgrade H.C. Wainwright Buy → Neutral
Mar-08-18Reiterated B. Riley FBR, Inc. Buy $10 → $5
Oct-19-17Resumed FBR & Co. Buy $10
Mar-16-17Reiterated Rodman & Renshaw Buy $6 → $9
Jan-30-17Upgrade Laidlaw Neutral → Buy $8
Jan-05-17Upgrade Rodman & Renshaw Neutral → Buy $2.50 → $6
Dec-23-16Reiterated Rodman & Renshaw Neutral $2 → $2.50
Jul-19-16Reiterated FBR Capital Outperform $17 → $9
Jul-19-16Downgrade Noble Financial Buy → Hold
Jul-18-16Downgrade Rodman & Renshaw Buy → Neutral $2
Mar-16-16Initiated Northland Capital Outperform
Mar-14-16Reiterated Ascendiant Capital Markets Buy $11 → $12
Feb-17-16Resumed FBR Capital Outperform $17
Dec-03-14Reiterated MLV & Co Buy $12.50 → $14
Nov-07-14Initiated MLV & Co Buy $12.50
Apr-22-14Initiated Laidlaw Buy $19
Nov-19-13Initiated Aegis Capital Buy $60
Jun-15-21 08:30AM  
Jun-08-21 08:30AM  
Jun-02-21 08:30AM  
May-27-21 08:30AM  
May-14-21 08:30AM  
May-12-21 04:05PM  
02:30PM  
May-05-21 08:30AM  
Apr-06-21 08:30AM  
Mar-30-21 08:30AM  
Mar-14-21 04:52AM  
Mar-11-21 06:05PM  
04:05PM  
02:30PM  
Mar-04-21 04:05PM  
Jan-20-21 08:30AM  
Jan-13-21 08:03PM  
04:02PM  
08:30AM  
Dec-17-20 08:55AM  
Nov-10-20 08:30AM  
Oct-26-20 08:30AM  
Sep-09-20 08:30AM  
Aug-25-20 08:30AM  
Aug-24-20 07:27AM  
Aug-06-20 08:30AM  
Jul-15-20 08:30AM  
Jul-08-20 08:30AM  
Jun-25-20 10:58PM  
Jun-22-20 10:23AM  
Jun-19-20 03:32PM  
May-20-20 08:30AM  
May-12-20 08:30AM  
Mar-12-20 08:30AM  
Jan-27-20 08:30AM  
Jan-23-20 08:30AM  
Jan-22-20 10:00AM  
Jan-21-20 08:30AM  
Dec-20-19 08:30AM  
Dec-02-19 08:30AM  
Nov-18-19 08:52AM  
Nov-13-19 08:30AM  
Nov-07-19 08:30AM  
Sep-20-19 05:14PM  
Sep-19-19 12:02PM  
10:29AM  
Sep-17-19 08:30AM  
Aug-08-19 05:30AM  
Jul-25-19 12:58PM  
Jul-11-19 11:31AM  
Jun-27-19 08:30AM  
May-08-19 04:05PM  
11:39AM  
Apr-29-19 09:13AM  
Apr-15-19 12:08PM  
Apr-03-19 08:19AM  
Apr-02-19 06:00AM  
Mar-29-19 12:45PM  
Mar-14-19 08:30AM  
Mar-06-19 08:30AM  
Mar-04-19 08:30AM  
Feb-27-19 08:30AM  
Jan-07-19 08:30AM  
Jan-04-19 07:56AM  
Nov-13-18 04:05PM  
Oct-16-18 10:32AM  
Oct-08-18 06:28PM  
Sep-28-18 09:59AM  
Aug-17-18 09:12AM  
Aug-16-18 08:30AM  
Aug-09-18 04:05PM  
Jun-06-18 01:38PM  
Jun-04-18 07:30AM  
May-14-18 10:27AM  
06:30AM  
May-10-18 07:30AM  
Apr-30-18 07:30AM  
Mar-26-18 07:30AM  
Mar-07-18 04:05PM  
12:00PM  
Mar-06-18 07:30AM  
Mar-05-18 07:30AM  
Feb-21-18 08:30AM  
Feb-15-18 07:30AM  
Dec-12-17 07:40AM  
Dec-11-17 07:30AM  
Nov-14-17 04:05PM  
12:00PM  
06:49AM  
Nov-09-17 08:30AM  
Nov-07-17 08:30AM  
06:33AM  
Oct-27-17 08:30AM  
Oct-23-17 07:30AM  
Oct-17-17 09:53AM  
Oct-04-17 08:30AM  
Sep-12-17 08:30AM  
Sep-05-17 08:30AM  
Aug-14-17 04:05PM  
12:10PM  
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gonyer David APresident and CEODec 14Sale2.9423,95470,425339,782Dec 14 08:58 PM
Gonyer David APresident and CEODec 11Sale2.9048,046139,333363,736Dec 14 08:58 PM
D'Onofrio Matthew JExec VP, Chief Bus. OfficerDec 11Sale2.9140,357117,439283,997Dec 14 08:56 PM
D'Onofrio Matthew JExec VP, Chief Bus. OfficerDec 10Sale2.955,64316,647324,354Dec 14 08:56 PM
Gonyer David APresident and CEODec 09Option Exercise0.4072,00028,800411,782Dec 11 08:43 PM
D'Onofrio Matthew JExec VP, Chief Bus. OfficerDec 09Option Exercise0.4046,00018,400329,997Dec 11 08:41 PM